Source: European Journal of Pharmaceutics and Biopharmaceutics. Unidades: ICB, FCFRP
Subjects: PSORÍASE, RNA, MEDICAMENTO TÓPICO, NANOPARTÍCULAS
ABNT
DEPIERI, Lívia Vieira et al. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase. European Journal of Pharmaceutics and Biopharmaceutics, v. 105, p. 50-58, 2016Tradução . . Disponível em: https://doi.org/10.1016/j.ejpb.2016.05.012. Acesso em: 18 nov. 2024.APA
Depieri, L. V., Borgheti-Cardoso, L. N., Campos, P. M., Otaguiri, K. K., Vicentini, F. T. M. de C., Lopes, L. B., et al. (2016). RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase. European Journal of Pharmaceutics and Biopharmaceutics, 105, 50-58. doi:10.1016/j.ejpb.2016.05.012NLM
Depieri LV, Borgheti-Cardoso LN, Campos PM, Otaguiri KK, Vicentini FTM de C, Lopes LB, Fonseca MJV, Bentley MVLB. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; 105 50-58.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejpb.2016.05.012Vancouver
Depieri LV, Borgheti-Cardoso LN, Campos PM, Otaguiri KK, Vicentini FTM de C, Lopes LB, Fonseca MJV, Bentley MVLB. RNAi mediated IL-6 in vitro knockdown in psoriasis skin model with topical siRNA delivery system based on liquid crystalline phase [Internet]. European Journal of Pharmaceutics and Biopharmaceutics. 2016 ; 105 50-58.[citado 2024 nov. 18 ] Available from: https://doi.org/10.1016/j.ejpb.2016.05.012